Vaccination

FDA advisers weigh COVID-19 booster shots for fall

Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...

Diseases, Conditions, Syndromes

Omicron lasts three days less than Delta for boosted: study

People who are vaccinated and have had a booster shot against COVID-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

Vaccination

FDA panel meets to craft future vaccine strategy

An advisory panel to the U.S. Food and Drug Administration will meet Wednesday to discuss the best way forward with coronavirus vaccines, as evidence grows that variants are eroding the power of the country's current shots.

Vaccination

German panel recommends booster for recipients of 4 vaccines

Germany's independent vaccination advisory panel is recommending a booster shot with a messenger RNA vaccine for people who have had a full course of four Chinese, Indian and Russian COVID-19 vaccines that aren't currently ...

Vaccination

Second COVID-19 booster: who can get one, and when?

Following much debate among public health experts about the benefits of another COVID-19 booster, the U.S. Food and Drug Administration could approve second boosters of the mRNA vaccines as an option for people 50 and older ...

page 17 from 36